The objectives of this study were to identify the characteristics of c
hildren who required regional anesthesia for pain associated with term
inal malignancy and to identify the safety, tolerability and effective
ness of regional anesthesia as an analgesic modality in terminal pedia
tric malignancy, A retrospective examination was made of the medical r
ecords of children who died of malignancy following treatment at the D
ana-Farber Cancer Institute and Children's Hospital, Boston, Massachus
etts, and who required either epidural or subarachnoid infusions, or n
eurolytic blockade for pain management(June, 1986 - April, 1994) durin
g the terminal phase of their illness, Eleven patients were identified
, with a duration of epidural or subarachnoid infusions ranging from 3
days to 7 weeks. Indications for this intervention included limiting
side effects of opioids, neuropathic pain unresponsive to either rapid
escalation of opioids or massive opioid infusions, analgesia for thor
acocenteses for the drainage of malignant pleural effusions and instil
lation of intrapleural chemotherapy. Pain was localized to one area in
all patients. Analgesia was judged to be satisfactory in all cases af
ter regional anesthesia was instituted and remained satisfactory in al
l cases throughout the treatment course, Complications associated with
regional anesthesia included dural puncture headache and mild respira
tory depression, Five patients were nursed at home with either epidura
l or subarachnoid infusions,